Synovo 10 years anniversary on Nov 2014 was a total success. Thank you!
Orphan designation for SYD003 for the treatment of pancreatic cancer. Granted by the European Medicines Agency (EMA) on 22 August 2014 and by the US Food and Drug Administration (FDA) on 20 October 2014.
Our compound SYD0073 has been granted orphan designation (EU/3/14/1239) by the European Medicines Agency (EMA) for the treatment of cystic fibrosis.